MedTrace Logo

Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fed Conditions

NCT01155960 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2010-07-02

No results posted yet for this study

Summary

The purpose of this study is to compare bioavailability in healthy, post menopausal women subjects under fed conditions.

Conditions

  • Healthy

Interventions

DRUG

Anastrozole

Anastrozole Tablets 1 mg of Dr.Reddy's Laboratories Limited

Sponsors & Collaborators

  • Dr. Reddy's Laboratories Limited

    lead INDUSTRY

Principal Investigators

  • Ronak Modi, MBBS · BA Research India Ltd.,

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
37 Years
Max Age
67 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2008-06-30
Completion
2008-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01155960 on ClinicalTrials.gov